Matt Katz, Managing Partner and Head of Retail & Consumer Packaged Goods, Nick Kramer, Vice President of Digital and Analytics, and Chris Ventry, Vice President of Retail & Consumer Packaged Goods, recently published an article in Chain Drug Review. The trio takes a look at the impact of the COVID-19 pandemic on chain drug stores and how digital transformation can reimagine business and operating models to preserve market share, seize opportunity, and control operating expense.
Chain Drug Review July 27 2020
Growth Equity Today: Adapting Buyout Playbooks to Accelerate Performance
Growth equity firms today face extraordinary market characteristics. Hold periods have extended, many investments are ‘upside down,’ and fund IRRs, on average, have turned negative. Additionally, capital costs have increased, and raising capital has grown increasingly difficult.
Learn More
Matt Katz shares insights into the changing DTC retail market in this Retail Dive article.
Learn More
As customers continue to demand more personalization and transparency from retailers, Nick Kramer highlights how AI can make this easier for companies in this Retail TouchPoints article.
Learn More